8-K: Current report filing
Published on January 25, 2008
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported): January 18,
2008
OPKO
Health, Inc.
(Exact
Name of Registrant as Specified in Charter)
|
Delaware
(State
or other
jurisdiction
of
incorporation)
|
|
000-26648
(Commission
File
Number)
|
|
75-2402409
(IRS
Employer
Identification
No.)
|
|
4400
Biscayne Blvd
Suite 1180
Miami,
Florida 33137
(Address
of Principal Executive Offices)
|
Registrant’s
telephone number, including area code: (305) 575-4138
____________________________________________________
(Former
Name or Former Address, if Changed Since Last Report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 5.02.
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment
of
Certain Officers; Compensatory Arrangements of Certain
Officers.
|
On
January 18, 2008, David Eichler resigned
as a member of the Board
of
Directors of OPKO Health, Inc. (the “Company”). The resignation of Mr. Eichler
did not involve any disagreement with the Company. Effective as of January
24,
2008, Richard C. Pfenniger, Jr. was appointed as a director of the Company
to
fill the vacancy created by Mr. Eichler’s resignation. Mr. Pfenniger was also
appointed to serve as Chairman of the Company’s Audit Committee.
Effective
January 24, 2008, the Board also voted to increase the size of the Board from
nine to ten directors, and the Board appointed Thomas E. Beier to fill the
additional seat created on the Board. Mr. Beier was appointed to serve on the
Company’s Audit Committee and the Compensation Committee.
|
ITEM 9.01.
|
Financial
Statements and Exhibits.
|
(d) Exhibits
|
|
99.1
|
|
Press
Release dated January 25, 2008
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
OPKO
Health, Inc.
|
||
| |
|
|
| By: |
/s/
Rao Uppaluri
|
|
|
Name:
Rao
Uppaluri
|
||
|
Title:
Chief
Financial Officer
|
||
Date
January 25, 2008